Detecting Cancer Early: Can Blood Tests Like Galleri Identify Cancer Markers?
Pre-Symptom Detection
Most people think their yearly check-up will find serious health problems early. The truth is that only 14% of cancers are found through routine screenings—which means most cancers grow unnoticed until symptoms show up. By then, treatment options are fewer and outcomes are less certain.
However, your body gives subtle, but important information long before symptoms appear. Biomarkers—measurable indicators of biological processes or disease states in the body—can show cancer risk at its earliest stages. Checking these markers regularly can help you take action early, instead of waiting until it’s too late.
Limits of Routine Screenings
Most standard screenings only check for five common cancers: breast, cervical, colorectal, lung, and prostate. However, there are over 50 types of cancer. This means many cancers go undetected until later stages. At that point, treatment is more complex, and outcomes are less favorable. That’s why it’s vital to take testing further with advanced cancer screening.
Can Blood Tests Detect Cancer?
Not all blood tests are designed for cancer detection. However, advanced biomarker testing can identify early warning signs of cancer risk, allowing for timely intervention.
What Biomarkers Reveal About Cancer Risk
Cancer develops over time, often leaving measurable signals in the body. Advanced biomarkers testing helps monitor immune response and abnormal cellular activity—offering early insight into potential risks down the line.

Key Cancer-Related Biomarkers to Monitor
- PSA (Prostate-Specific Antigen): Elevated levels may indicate prostate cancer, but PSA alone is not diagnostic. Instead, PSA levels provide insight into prostate health, signaling when further evaluation is necessary.
- Amylase & Lipase: These pancreatic enzymes can reveal digestive disorders, inflammatory conditions, and even pancreatic cancer.
- TgAb (Thyroglobulin Antibodies): This test helps monitor thyroid function and detect thyroid-related autoimmune disorders, including Hashimoto’s disease, and may be useful in tracking certain thyroid cancers.
- Monocytes & Neutrophils: Abnormal levels of these white blood cells can indicate infections, chronic disease, inflammatory disorders, or specific cancers such as leukemia.
- WBC Count, Lymphocytes, Eosinophils, Basophils: These immune cells help detect blood cancers and immune system abnormalities that may indicate underlying malignancies.
- Hemoglobin, Platelet Count, Hematocrit: These markers provide insight into red blood cell health, clotting function, and bone marrow activity, helping to identify anemia, clotting disorders, and certain cancers
Advanced Cancer Screening Tools
The annual physical is not enough to gauge cancer risk. Advanced cancer screening is essential if you want to stay ahead of potential risks and catch it early—when you can proactively do something about it.

The Galleri Multi-Cancer Early Detection Test by GRAIL
There’s no singular way to avoid cancer, but you can take control and stay informed of your body’s health status by testing for cancer markers. One option is the Galleri Multi-Cancer Early Detection Test by GRAIL—This revolutionary blood test screens for 50+ types of cancer by detecting cancer signals in the blood. It represents a major advancement in early cancer detection—before symptoms may even present—that traditional screenings like mammograms or colonoscopies might miss.
Function members can now access the Galleri test anytime for an additional cost—test yearly and make it part of your annual health routine.
Multi-Cancer Early Detection Tests Can Change Outcomes
These tests can make all the difference:
- Can detect cancer up to 4 years earlier than conventional screenings.
- Reduces late-stage diagnosis by up to 78%.
- Leads to lower treatment costs and improved quality of life.
Catch Cancer Early
When diagnosed at the earliest stages (Stage 0 or 1), survival odds for breast cancer, thyroid cancer, melanoma, uterine cancer, ovarian cancer, and cervical cancer rise dramatically—proof that early screenings truly matter.

Cancer Prevention Tips
Wondering how to avoid cancer? Genetics play a role, but when it comes to overall cancer risk, your daily habits should not be overlooked. Your everyday choices can play a powerful role in increasing or decreasing risk,so act wisely—here’s how:

Make Time to Exercise
Just 3-4 minutes per day reduces cancer risk by improving circulation, regulating hormones, and strengthening immune function. Even small daily movements, such as brisk walking, or light resistance training, can have significant long-term health benefits.
Maintain a Healthy Weight
Excess body weight and particularly fat around the abdomen, contributes to chronic inflammation and increased hormone levels, which are linked to 13 types of cancer.
Prioritize Whole, Unprocessed Foods
A diet rich in vegetables, fruits, lean proteins, and healthy fats reduces oxidative stress, inflammation, and supports immune function. Cooking at home with fresh ingredients and limiting ultra-processed foods is worth it—they’ve been shown to reduce the risk of cancer.
Don’t Smoke
Tobacco use remains the leading preventable cause of cancer. Quitting smoking improves cardiovascular health and lowers the risk of multiple cancers over time.
Cut Back on Alcohol
The more alcohol you consume, the more you increase the risk of cancer. Even one less drink per day significantly lowers the risk of head, neck, liver, breast, and cancers.
Use Sunscreen Daily
UV exposure is a significant risk factor for skin cancer, the most commonly diagnosed cancer in the U.S. Proper sun protection with SPF 30+ not only prevents sunburn but also reduces long-term melanoma risk.
Cancer doesn’t wait, and neither should you. With colorectal cancer on the rise in Americans under 50, breast cancer rates rising in women, and pancreatic cancer cases rising globally—there’s no better time than the present to take control. You’re never too young to prioritize your health. And by taking charge through advanced biomarker testing, yearly multi-cancer early detection testing, and strategic lifestyle choices, you can stay ahead of your health as it changes and increase your chances of catching cancer early.
Takeaway
Routine cancer screenings alone are not enough. A smarter, science-driven approach for preventing cancer and finding cancer early should combine blood testing for cancer biomarkers, advanced early detection testing (like the Galleri test), and proactive lifestyle changes to reduce risk and catch potential issues at their earliest, most treatable stage. The decisions you make today—from daily habits to investing in yearly testing—may determine whether cancer is caught early or remains undetected.
Your health is in your hands. Make your choices count. Join Function, test annually, and monitor your lab results to stay informed about the health of your whole body.
View References
- National Opinion Research Center (NORC), University of Chicago. Cancer Detection Tool. cancerdetection.norc.org. https://cancerdetection.norc.org/
- Philipson T, Durie T, Cong Z, A. Mark Fendrick. The aggregate value of cancer screenings in the United States: full potential value and value considering adherence. BMC Health Services Research. 2023;23(1). doi:https://doi.org/10.1186/s12913-023-09738-4
- Klein EA, Madhavan S, Beer TM, et al. Dying to find out: The cost of time at the dawn of the multicancer early detection era. Cancer Epidemiol Biomarkers Prev. 2023;32(8):1003-1010. doi:10.1158/1055-9965.EPI-22-1275
- Tafazzoli A, Ramsey SD, Shaul A, et al. The potential value-based price of a multi-cancer early detection genomic blood test to complement current single cancer screening in the USA. Pharmacoeconomics. 2022;40(11):1107-1117. doi:10.1007/s40273-022-01181-3
- B. Krishna Prasanth, Saad Alkhowaiter, Gaurav Sawarkar, B. Divya Dharshini, Baskaran AR. Unlocking Early Cancer Detection: Exploring Biomarkers, Circulating DNA, and Innovative Technological Approaches. Cureus. Published online December 25, 2023. doi:https://doi.org/10.7759/cureus.51090
- CDC. Cancer Screening Tests. Cancer. Published May 7, 2024. https://www.cdc.gov/cancer/prevention/screening.html
- National Cancer Institute. Cancer Types. National Cancer Institute. Published 2019. https://www.cancer.gov/types
- David MK, Leslie SW. Prostate Specific Antigen (PSA). PubMed. Published 2020. https://www.ncbi.nlm.nih.gov/books/NBK557495/
- Asamer E, Szkandera J, Gibiser M, et al. Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: a retrospective analysis. BMC Cancer. 2018;18(1):1000. doi:10.1186/s12885-018-4918-0
- Puckett Y, Garfield K. Pancreatic Cancer. Nih.gov. Published July 28, 2019. https://www.ncbi.nlm.nih.gov/books/NBK518996/
- Mincer DL, Jialal I. Hashimoto Thyroiditis. Nih.gov. Published 2023. https://www.ncbi.nlm.nih.gov/books/NBK459262/
- Spencer C, Fatemi S. Thyroglobulin antibody (TgAb) methods – Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 2013;27(5):701-712. doi:https://doi.org/10.1016/j.beem.2013.07.003
- Chen X, Li Y, Xia H, Chen YH. Monocytes in Tumorigenesis and Tumor Immunotherapy. Cells. 2023;12(13):1673. doi:https://doi.org/10.3390/cells12131673
- Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. doi:10.1093/jnci/dju124
- Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. American Journal of Hematology. 2024;99(6). doi:https://doi.org/10.1002/ajh.27271
- Eden RE, Coviello JM. Cancer, Chronic Myelogenous Leukemia (CML, Chronic Granulocytic Leukemia). PubMed. Published 2020. https://www.ncbi.nlm.nih.gov/books/NBK531459/
- Moreira A, Leisgang W, Schuler G, Heinzerling L. Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy. Immunotherapy. 2017;9(2):115-121. doi:10.2217/imt-2016-0138
- Marone G, Schroeder JT, Mattei F, et al. Is There a Role for Basophils in Cancer? Frontiers in Immunology. 2020;11. doi:https://doi.org/10.3389/fimmu.2020.02103
- Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med. 2007;167(17):1837-1844. doi:10.1001/archinte.167.17.1837
- He Y, Ren T, Ji C, Zhao L, Wang X. The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer. Frontiers in Pharmacology. 2024;15. doi:https://doi.org/10.3389/fphar.2024.1456833
- Giannakeas V, Kotsopoulos J, Cheung MC, et al. Analysis of platelet count and new cancer diagnosis over a 10-year period. JAMA Netw Open. 2022;5(1):e2141633. doi:10.1001/jamanetworkopen.2021.41633
- Chen J, Li Y, Cui H. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer. Archives of Gynecology and Obstetrics. 2020;303(3):767-775. doi:https://doi.org/10.1007/s00404-020-05822-w
- Blood test to detect cancer signal presence. English. March 13, 2023. Accessed December 4, 2024. https://www.galleri.com/what-is-galleri/types-of-cancer-detected
- American Cancer Society. Multi-cancer Early Detection Tests | MCED | GRAIL Galleri Test. www.cancer.org. Accessed June 22, 2023. https://www.cancer.org/cancer/screening/multi-cancer-early-detection-tests.html
- Than M, Witherspoon J, Shami J, Patil P, Avanish Saklani. Diagnostic miss rate for colorectal cancer: an audit. Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology. 2015;28(1):94. https://pmc.ncbi.nlm.nih.gov/articles/PMC4290010/
- Franklin J, Hayes J, Knippa E, Dogan B. False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis. Breast cancer research and treatment. Published online March 14, 2024. doi:https://doi.org/10.1007/s10549-024-07259-0
- Wallace MB, Sharma P, Bhandari P, et al. Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia. Gastroenterology. 2022;163(1). doi:https://doi.org/10.1053/j.gastro.2022.03.007
- Chen X, Gole J, Gore A, et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat Commun. 2020;11(1):3475. doi:10.1038/s41467-020-17316-z
- Hubbell E, Clarke CA, Aravanis AM, Berg CD. Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test. Cancer Epidemiology and Prevention Biomarkers. 2021;30(3):460-468. doi:https://doi.org/10.1158/1055-9965.EPI-20-1134
- Whitaker K. Earlier diagnosis: the importance of cancer symptoms. Thelancet.com. Accessed January 24, 2025. https://www.thelancet.com/journals/lanonc/article/piis1470-2045(19)30658-8/fulltext
- American Cancer Society. Survival rates for breast cancer. www.cancer.org. Published March 1, 2023.https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html
- CDC. U.S. Cancer Statistics Breast Cancer Stat Bite. United States Cancer Statistics. Published June 5, 2024. https://www.cdc.gov/united-states-cancer-statistics/publications/breast-cancer-stat-bite.html
- National Cancer Institute. Cancer of the Thyroid - Cancer Stat Facts. SEER. https://seer.cancer.gov/statfacts/html/thyro.html
- Heistein J, Acharya U. Cancer, Malignant Melanoma. PubMed. Published May 22, 2023. https://www.ncbi.nlm.nih.gov/books/NBK470409/
- National Cancer Institute. Melanoma of the Skin - Cancer Stat Facts. SEER. Published 2018. https://seer.cancer.gov/statfacts/html/melan.html
- Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA: A Cancer Journal for Clinicians. 2025;75(1). doi:https://doi.org/10.3322/caac.21871
- American Cancer Society. Survival Rates for Endometrial Cancer. www.cancer.org. Published January 17, 2024. https://www.cancer.org/cancer/types/endometrial-cancer/detection-diagnosis-staging/survival-rates.html
- Burke W, Barkley J, Barrows E, et al. Executive Summary of the Ovarian Cancer Evidence Review Conference. Obstet Gynecol. 2023;142(1):179-195. doi:10.1097/AOG.0000000000005211
- American Cancer Society. Ovarian Cancer Survival Rates | Ovarian Cancer Prognosis. www.cancer.org. Published March 1, 2023. https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/survival-rates.html
- National Cancer Institute. Cervical Cancer Prognosis and Survival Rates - NCI. www.cancer.gov. Published October 13, 2022. https://www.cancer.gov/types/cervical/survival
- Imyanitov EN, Kuligina ES, Sokolenko AP, et al. Hereditary cancer syndromes. World Journal of Clinical Oncology. 2023;14(2):40-68. doi:https://doi.org/10.5306/wjco.v14.i2.40
- Stamatakis E, Ahmadi MN, Gill JMR, et al. Vigorous intermittent lifestyle physical activity and cancer incidence among nonexercising adults: a prospective cohort study. JAMA Oncol. 2023;9(9):1225-1233. doi:10.1001/jamaoncol.2023.2343
- Anderson E, Durstine JL. Physical activity, exercise, and Chronic diseases: a Brief Review. Sports Medicine and Health Science. 2019;1(1):3-10. doi:https://doi.org/10.1016/j.smhs.2019.08.006
- Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet Public Health. 2022;7(3):e219-e228. doi:https://doi.org/10.1016/S2468-2667(21)00302-9
- Shailendra P, Baldock KL, Li LSK, Bennie JA, Boyle T. Resistance Training and Mortality Risk: A Systematic Review and Meta-Analysis. American Journal of Preventive Medicine. 2022;63(2):277-285. doi:https://doi.org/10.1016/j.amepre.2022.03.020
- American Cancer Society. Excess body weight and cancer risk. Cancer.org. Updated December 19, 2024. Accessed January 23, 2025. https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/body-weight-and-cancer-risk.html
- Scheiber A, Mank V. Anti-Inflammatory Diets. PubMed. Published October 28, 2023. https://www.ncbi.nlm.nih.gov/books/NBK597377/
- Cordova R, Viallon V, Fontvieille E, et al. Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Lancet Reg Health Eur. Published online November 13, 2023. doi:10.1016/j.lanepe.2023.100771
- Centers for Disease Control and Prevention. About Health Effects of Cigarette Smoking. Smoking and Tobacco Use. Published September 17, 2024. https://www.cdc.gov/tobacco/about/index.html
- American Cancer Society. Health Benefits of Quitting Smoking Over Time. Cancer.org. Published 2024.https://www.cancer.org/cancer/risk-prevention/tobacco/guide-quitting-smoking/benefits-of-quitting-smoking-over-time.html
- Choi S, Chang J, Kim K, Park SM, Lee K. Effect of Smoking Cessation and Reduction on the Risk of Cancer in Korean Men: A Population Based Study. Cancer Research and Treatment. 2018;50(4):1114-1120. doi:https://doi.org/10.4143/crt.2017.326
- Di Credico G, Polesel J, Dal Maso L, et al. Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. British Journal of Cancer. 2020;123(9):1456-1463. doi:https://doi.org/10.1038/s41416-020-01031-z
- U.S. Department of Health and Human Services. Alcohol and Cancer Risk 2025.; 2024. https://www.hhs.gov/sites/default/files/oash-alcohol-cancer-risk.pdf
- CDC. Sun Safety Facts. Skin Cancer. Published May 3, 2024. https://www.cdc.gov/skin-cancer/sun-safety/index.html
- American Academy of Dermatology Association. Skin Cancer. Aad.org. Published April 22, 2022. https://www.aad.org/media/stats-skin-cancer
- FDA. Sunscreen: How to help protect your skin from the sun. U.S. Food and Drug Administration. Published 2019. https://www.fda.gov/drugs/understanding-over-counter-medicines/sunscreen-how-help-protect-your-skin-sun
- Lazovich D, Vogel RI, Berwick M, Weinstock MA, Warshaw EM, Anderson KE. Melanoma risk in relation to use of sunscreen or other sun protection methods. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2011;20(12):2583-2593. doi:https://doi.org/10.1158/1055-9965.EPI-11-0705
- Sander M, Sander M, Burbidge T, Beecker J. The Efficacy and Safety of Sunscreen Use for the Prevention of Skin Cancer. Canadian Medical Association Journal. 2020;192(50):E1802-E1808. doi:https://doi.org/10.1503/cmaj.201085
- Sung H, Siegel RL, Mathieu Laversanne, et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. The Lancet Oncology. Published online December 1, 2024. doi:https://doi.org/10.1016/s1470-2045(24)00600-4
- Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Network Open. 2024;7(1):e2353331. doi:https://doi.org/10.1001/jamanetworkopen.2023.53331
- Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. World Journal of Gastroenterology. 2022;28(32):4698-4715. doi:https://doi.org/10.3748/wjg.v28.i32.4698